Cutting Time, Cost, and Material for Viral Clearance Studies: A Proven Dual Virus Spike Approach
Summary KBI Biopharma and Texcell North America developed a proven dual virus spike approach for viral clearance...
Webinars
Reducing CMC Risk Through TIME with KBI's Proven Analytical & Formulation Expertise
Speaker: Deanna Hunt, Senior Director of Business Development, Analytical and Formulation Sciences, KBI Biopharma...
Choosing The Ideal CDMO Partner For Cell Line Development
Author: Séverine Fagète, Ph.D. The commercial production of recombinant proteins, including antibodies and enzymes,...